3. Toronto Lung Transplant Group. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med. 1986; 314:1140–5. DOI:
10.1056/NEJM198605013141802. PMID:
3515192.
4. Chambers DC, Cherikh WS, Goldfarb SB, Hayes D Jr, Kucheryavaya AY, Toll AE, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation:thirty-fifth adult lung and heart-lung transplant report-2018; focus theme:multiorgan transplantation. J Heart Lung Transplant. 2018; 37:1169–83. DOI:
10.1016/j.healun.2018.07.020. PMID:
30293613.
5. Punch JD, Hayes DH, LaPorte FB, McBride V, Seely MS. Organ donation and utilization in the United States 1996-2005. Am J Transplant. 2007; 7(5 Pt 2):1327–38. DOI:
10.1111/j.1600-6143.2007.01779.x. PMID:
17428283.
6. Fisher AJ, Donnelly SC, Pritchard G, Dark JH, Corris PA. Objective assessment of criteria for selection of donor lungs suitable for transplantation. Thorax. 2004; 59:434–7. DOI:
10.1136/thx.2003.007542. PMID:
15115876. PMCID:
PMC1747005.
7. Glanville AR, Estenne M. Indications, patient selection and timing of referral for lung transplantation. Eur Respir J. 2003; 22:845–52. DOI:
10.1183/09031936.03.00039003.
9. Orens JB, Boehler A, de Perrot M, Estenne M, Glanville AR, Keshavjee S, et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant. 2003; 22:1183–200. DOI:
10.1016/S1053-2498(03)00096-2.
10. Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, et al. The registry of the International Society for Heart and Lung Transplantation:thirty-first adult lung and heart-lung transplant report--2014; focus theme: retransplantation. J Heart Lung Transplant. 2014; 33:1009–24. DOI:
10.1016/j.healun.2014.08.004. PMID:
25242125.
11. Gao W, Liu D, Li D, Che X, Cui G. Effects of hypercapnia on T cells in lung ischemia/reperfusion injury after lung transplantation. Exp Biol Med (Maywood). 2014; 239:1597–605. DOI:
10.1177/1535370214542072. PMID:
25013165.
12. Diamond JM, Lee JC, Kawut SM, Shah RJ, Localio AR, Bellamy SL, et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2013; 187:527–34. DOI:
10.1164/rccm.201210-1865OC. PMID:
23306540. PMCID:
PMC3733407.
13. Hoechter DJ, von Dossow V. Lung transplantation:from the procedure to managing patients with lung transplantation. Curr Opin Anaesthesiol. 2016; 29:8–13. DOI:
10.1097/ACO.0000000000000268. PMID:
26545145.
14. Vos R, Ruttens D, Verleden SE, Vandermeulen E, Bellon H, Van Herck A, et al. High-dose vitamin D after lung transplantation:a randomized trial. J Heart Lung Transplant. 2017; 36:897–905. DOI:
10.1016/j.healun.2017.03.008. PMID:
28365177.
15. Hayes D Jr, Higgins RS, Black SM, Wehr AM, Lehman AM, Kirkby S, et al. Effect of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis after lung transplantation:an analysis of the United Network of Organ Sharing registry. J Heart Lung Transplant. 2015; 34:430–7. DOI:
10.1016/j.healun.2014.09.004. PMID:
25444371.
16. Nadrous HF, Pellikka PA, Krowka MJ, Swanson KL, Chaowalit N, Decker PA, et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest. 2005; 128:2393–9. DOI:
10.1378/chest.128.4.2393. PMID:
16236900.
17. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest. 2006; 129:746–52. DOI:
10.1378/chest.129.3.746. PMID:
16537877.
18. Wrobel JP, Thompson BR, Williams TJ. Mechanisms of pulmonary hypertension in chronic obstructive pulmonary disease:a pathophysiologic review. J Heart Lung Transplant. 2012; 31:557–64. DOI:
10.1016/j.healun.2012.02.029. PMID:
22502811.
19. Takenaka K. Nimura lecture:why are you evaluating RV function in patients with pulmonary arterial hypertension? J Echocardiogr. 2019; 17:1–4. DOI:
10.1007/s12574-018-0400-x. PMID:
30291508.
20. Howard LS, Grapsa J, Dawson D, Bellamy M, Chambers JB, Masani ND, et al. Echocardiographic assessment of pulmonary hypertension:standard operating procedure. Eur Respir Rev. 2012; 21:239–48. DOI:
10.1183/09059180.00003912. PMID:
22941889.
21. Izbicki G, Ben-Dor I, Shitrit D, Bendayan D, Aldrich TK, Kornowski R, et al. The prevalence of coronary artery disease in endstage pulmonary disease: is pulmonary fibrosis a risk factor? Respir Med. 2009; 103:1346–9. DOI:
10.1016/j.rmed.2009.03.012. PMID:
19362458.
22. Savarino E, Carbone R, Marabotto E, Furnari M, Sconfienza L, Ghio M, et al. Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. Eur Respir J. 2013; 42:1322–31. DOI:
10.1183/09031936.00101212. PMID:
23471347.
23. Hausmann D, Daniel WG, Mügge A, Heublein B, Hamm M, Schäfers HJ, et al. Imaging of pulmonary artery and vein anastomoses by transesophageal echocardiography after lung transplantation. Circulation. 1992; 86(5 Suppl):II251–8. PMID:
1424008.
27. Kachulis B, Mitrev L, Jordan D. Intraoperative anesthetic management of lung transplantation patients. Best Pract Res Clin Anaesthesiol. 2017; 31:261–72. DOI:
10.1016/j.bpa.2017.04.004. PMID:
29110798.
29. Marczin N, Royston D, Yacoub M. Pro:lung transplantation should be routinely performed with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2000; 14:739–45. DOI:
10.1053/jcan.2000.18592. PMID:
11139121.
30. Ius F, Kuehn C, Tudorache I, Sommer W, Avsar M, Boethig D, et al. Lung transplantation on cardiopulmonary support:venoarterial extracorporeal membrane oxygenation outperformed cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2012; 144:1510–6. DOI:
10.1016/j.jtcvs.2012.07.095. PMID:
22944092.
31. Tudorache I, Sommer W, Kühn C, Wiesner O, Hadem J, Fühner T, et al. Lung transplantation for severe pulmonary hypertension-awake extracorporeal membrane oxygenation for postoperative left ventricular remodelling. Transplantation. 2015; 99:451–8. DOI:
10.1097/TP.0000000000000348. PMID:
25119128.
32. Aigner C, Wisser W, Taghavi S, Lang G, Jaksch P, Czyzewski D, et al. Institutional experience with extracorporeal membrane oxygenation in lung transplantation. Eur J Cardiothorac Surg. 2007; 31:468–73. DOI:
10.1016/j.ejcts.2006.11.049. PMID:
17223352.
33. Bermudez CA, Shiose A, Esper SA, Shigemura N, D'Cunha J, Bhama JK, et al. Outcomes of intraoperative venoarterial extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation. Ann Thorac Surg. 2014; 98:1936–42. DOI:
10.1016/j.athoracsur.2014.06.072. PMID:
25443002.
34. Biscotti M, Yang J, Sonett J, Bacchetta M. Comparison of extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation. J Thorac Cardiovasc Surg. 2014; 148:2410–5. DOI:
10.1016/j.jtcvs.2014.07.061. PMID:
25444203.
35. Machuca TN, Collaud S, Mercier O, Cheung M, Cunningham V, Kim SJ, et al. Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation. J Thorac Cardiovasc Surg. 2015; 149:1152–7. DOI:
10.1016/j.jtcvs.2014.11.039. PMID:
25583107.
36. Yu WS, Paik HC, Haam SJ, Lee CY, Nam KS, Jung HS, et al. Transition to routine use of venoarterial extracorporeal oxygenation during lung transplantation could improve early outcomes. J Thorac Dis. 2016; 8:1712–20. DOI:
10.21037/jtd.2016.06.18. PMID:
27499961. PMCID:
PMC4958818.
37. Pruszkowski O, Dalibon N, Moutafis M, Jugan E, Law-Koune JD, Laloë PA, et al. Effects of propofol vs sevoflurane on arterial oxygenation during one-lung ventilation. Br J Anaesth. 2007; 98:539–44. DOI:
10.1093/bja/aem039. PMID:
17347180.
38. Módolo NS, Módolo MP, Marton MA, Volpato E, Monteiro Arantes V, do Nascimento P Junior, et al. Intravenous versus inhalation anaesthesia for one-lung ventilation. Cochrane Database Syst Rev. 2013; 7:CD006313.
39. Chacko J, Rani U. Alveolar recruitment maneuvers in acute lung injury/acute respiratory distress syndrome. Indian J Crit Care Med. 2009; 13:1–6. DOI:
10.4103/0972-5229.53107. PMID:
19881171. PMCID:
PMC2772255.
40. Santos RS, Silva PL, Pelosi P, Rocco PR. Recruitment maneuvers in acute respiratory distress syndrome:the safe way is the best way. World J Crit Care Med. 2015; 4:278–86. DOI:
10.5492/wjccm.v4.i4.278. PMID:
26557478. PMCID:
PMC4631873.
41. Lee JG, Kim N, Nam KS, Suh JW, Hwang JS, Paik HC, et al. The effect of additional stepwise venous inflow on differential hypoxia of venoarterial extracorporeal membrane oxygenation. ASAIO J. Forthcoming. 2019.
42. Wang H, Gong M, Zhou B, Dai A. Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery. Adv Ther. 2009; 26:462–8. DOI:
10.1007/s12325-009-0019-4. PMID:
19381522.
43. Michelakis E, Tymchak W, Lien D, Webster L, Hashimoto K, Archer S. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation. 2002; 105:2398–403. DOI:
10.1161/01.CIR.0000016641.12984.DC. PMID:
12021227.
44. Hoeper MM, Olschewski H, Ghofrani HA, Wilkens H, Winkler J, Borst MM, et al. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. J Am Coll Cardiol. 2000; 35:176–82. DOI:
10.1016/S0735-1097(99)00494-5. PMID:
10636277.
45. Lee SH, Lee JG, Lee CY, Kim N, Chang MY, You YC, et al. Effects of intraoperative inhaled iloprost on primary graft dysfunction after lung transplantation:a retrospective single center study. Medicine (Baltimore). 2016; 95:e3975. DOI:
10.1097/MD.0000000000003975. PMID:
27399072. PMCID:
PMC5058801.
47. Sugita M, Ferraro P, Dagenais A, Clermont ME, Barbry P, Michel RP, et al. Alveolar liquid clearance and sodium channel expression are decreased in transplanted canine lungs. Am J Respir Crit Care Med. 2003; 167:1440–50. DOI:
10.1164/rccm.200204-312OC. PMID:
12738601.
48. Geube MA, Perez-Protto SE, McGrath TL, Yang D, Sessler DI, Budev MM, et al. Increased intraoperative fluid administration is associated with severe primary graft dysfunction after lung transplantation. Anesth Analg. 2016; 122:1081–8. DOI:
10.1213/ANE.0000000000001163. PMID:
26991618. PMCID:
PMC4800821.
50. den Hengst WA, Gielis JF, Lin JY, Van Schil PE, De Windt LJ, Moens AL. Lung ischemia-reperfusion injury:a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol. 2010; 299:H1283–99. DOI:
10.1152/ajpheart.00251.2010. PMID:
20833966.
51. Pereszlenyi A, Lang G, Steltzer H, Hetz H, Kocher A, Neuhauser P, et al. Bilateral lung transplantation with intra- and postoperatively prolonged ECMO support in patients with pulmonary hypertension. Eur J Cardiothorac Surg. 2002; 21:858–63. DOI:
10.1016/S1010-7940(02)00058-1. PMID:
12062275.
52. Moser B, Jaksch P, Taghavi S, Muraközy G, Lang G, Hager H, et al. Lung transplantation for idiopathic pulmonary arterial hypertension on intraoperative and postoperatively prolonged extracorporeal membrane oxygenation provides optimally controlled reperfusion and excellent outcome. Eur J Cardiothorac Surg. 2018; 53:178–85. DOI:
10.1093/ejcts/ezx212. PMID:
28950326. PMCID:
PMC5848802.
53. Seo M, Kim WJ, Choi IC. Anesthesia for non-pulmonary surgical intervention following lung transplantation:two cases report. Korean J Anesthesiol. 2014; 66:322–6. DOI:
10.4097/kjae.2014.66.4.322. PMID:
24851171. PMCID:
PMC4028563.
54. Beer A, Reed RM, Bölükbas S, Budev M, Chaux G, Zamora MR, et al. Mechanical ventilation after lung transplantation. An international survey of practices and preferences. Ann Am Thorac Soc. 2014; 11:546–53. DOI:
10.1513/AnnalsATS.201312-419OC. PMID:
24640938.
55. Barnes L, Reed RM, Parekh KR, Bhama JK, Pena T, Rajagopal S, et al. Mechanical ventilation for the lung transplant recipient. Curr Pulmonol Rep. 2015; 4:88–96. DOI:
10.1007/s13665-015-0114-8. PMID:
26495241. PMCID:
PMC4610154.